SEARCH

SEARCH BY CITATION

References

  • Agudo-López A., Miguel B. G., Fernàndez I. and Martinez A. M. (2010) Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. Neurosci. Lett. 470, 130133.
  • Araki Y., Tomita S., Yamaguchi H., Miyagi N., Sumioka A., Kirino Y. and Suzuki T. (2003) Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism. J. Biol. Chem. 278, 4944849458.
  • Billich A. and Ettmayer P. (2004) Fluorescence-based assay of sphingosine kinases. Anal. Biochem. 326, 114119.
  • Block C., Freyermuth S., Beyersmann D. and Malviya A. N. (1992) Role of cadmium in activating nuclear protein kinase C and the enzyme binding to nuclear protein. J. Biol. Chem. 267, 1982419828.
  • Blondeau N., Lai Y., Tyndall S. et al. (2007) Distribution of sphingosine kinase activity and mRNA in rodent brain. J. Neuochem. 103, 509517.
  • Brinkmann V. (2007) Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol. Ther. 115, 84105.
  • Carloni S., Mazzoni E. and Balduini W. (2004) Caspase-3 and calpain activities after acute and repeated ethanol administration during the rat brain growth spurt. J. Neurochem. 89, 197203.
  • Dakroub Z. and Kreydiyyeh S. I. (2012) Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells. J. Cell. Biochem. (in press).
  • Ding G., Sonoda H., Yu H., Kajimoto T., Goparaju S. K., Jahangeer S., Okada T. and Nakamura S. (2007) Protein kinase D-mediated phophorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem. 282, 2749327502.
  • Fischer I., Alliod C., Martinier N., Newcombe J., Brana C. and Pouly S. (2011) Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE 6, e23905.
  • French K. J., Zhuang Y., Maines L. W., Gao P., Wang W., Beljanski V., Upson J. J., Green C. L., Keller S. N. and Smith C. D. (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J. Pharmacol. Exp. Ther. 333, 129139.
  • Gomez L., Paillard M., Price M., Chen Q., Teixeira G., Spiegel S. and Lesnefsky E. J. (2011) A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Basic Res. Cardiol. 106, 13411353.
  • Hagen N., Van Veldhoven P. P., Proia R. L., Park H., Merrill A. H., Jr and van Echten-Deckert G. (2009) Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. J. Biol. Chem. 284, 1134611353.
  • Hait N. C., Bellamy A., Milstien S., Kordula T. and Spiegel S. (2007) Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282, 1205812065.
  • Hait N. C., Allegood J., Maceyka M. et al. (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 12541257.
  • Han J. Y., Jeong J. Y., Lee Y. K., Roh G. S., Kim H. J., Kang S. S., Cho G. J. and Choi W. S. (2006) Suppression of survival kinases and activation of JNK mediate ethanol-induced cell death in the developing rat brain. Neurosci. Lett. 398, 113117.
  • Hasegawa Y., Suzuki H., Sozen T., Rolland W. and Zhang J. H. (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368374.
  • He X., Huang C. L. and Schuchman E. H. (2009) Quantitative analysis of sphingosine-1-phosphate by HPLC after napthalene-2,3-dicarboxaldehyde (NDA) derivatization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 983990.
  • Ieraci A. and Herrera D. G. (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med. 3, e101.
  • Igarashi N., Okada T., Hayashi S., Fujita T., Jahangeer S. and Nakamura S. (2003) Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278, 4683246839.
  • Ikonomidou C., Bittigau P., Ishimaru M. J. et al. (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287, 10561060.
  • Johnson K. R., Becker K. P., Faccinetti M. M., Hannun Y. A. and Obeid L. M. (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277, 3525735262.
  • Kiebish M. A., Han X., Cheng H., Lunceford A., Clarke C. F., Moon H., Chuang J. H. and Seyfried T. N. (2008) Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J. Neurochem. 106, 299312.
  • Koppler P., Matter N. and Malviya A. N. (1993) Evidence for stereospecific inositol 1,3,4,5-[3H]tetrakisphosphate binding sites on rat liver nuclei. Delineating inositol 1,3,4,5-tetrakisphosphate interaction in nuclear calcium signaling process. J. Biol. Chem. 268, 2624826252.
  • Lee D. H., Jeon B. T., Jeong E. A., Kim J. S., Cho Y. W., Kim H. J., Kang S. S., Cho G. J., Choi W. S. and Roh G. S. (2010) Altered expression of sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 in mouse hippocampus after kainic acid treatment. Biochem. Biophys. Res. Commun. 393, 476480.
  • Li X. and Donowitz M. (2008) Fractionation of subcellular membrane vesicles of epithelial and nonepithelial cells by OptiPrep density gradient ultracentrifugation. Methods Mol. Biol. 440, 97110.
  • Liu H., Sugiura M., Nava V. E., Edsall L. C., Kono K., Poulton S., Milstien S., Kohama T. and Spiegel S. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275, 1951319520.
  • Liu H., Toman R. E., Goparaju S. K. et al. (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 278, 4033040336.
  • Maceyka M., Sankala H., Hait N. C. et al. (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280, 3711837129.
  • Malchinkhuu E., Sato K., Muraki T., Ishikawa K., Kuwabara A. and Okajima F. (2003) Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotien-induced stimulation of astroglial cell function. Biochem. J. 370, 817827.
  • Matyash V., Liebisch G., Kurzchalia T. V., Shevchenko A. and Schwudke D. (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 11371146.
  • Mizugishi K., Yamashita T., Olivera A., Miller G. F., Spiegel S. and Proia R. L. (2005) Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 1111311121.
  • Nayak D., Huo Y., Kwang W. X., Pushparaj P. N., Kumar S. D., Ling E. A. and Dheen S. T. (2010) Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166, 132144.
  • Nishimura H., Akiyama T., Irei I., Hamazaki S. and Sadahira Y. (2010) Cellular localization of sphingosine-1-phosphate receptor 1 expression in the human central nervous system. J. Histochem. Cytochem. 58, 847856.
  • Ogretmen B. and Hannun Y. A. (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604616.
  • Okada T., Ding G., Sonoda H., Kajimoto T., Haga Y., Khosrowbeygi A., Gao S., Miwa N., Jahangeer S. and Nakamura S. (2005) Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 280, 3631836325.
  • Okada T., Kajimoto T., Jahangeer S. and Nakamura S. (2009) sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system. Cell. Signal. 21, 713.
  • Olivera A. and Spiegel S. (1993) Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365, 557560.
  • Olney J. W., Tenkova T., Dikranian K., Qin Y. Q., Labruyere J. and Ikonomidou C. (2002) Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res. Dev. Brain Res. 133, 115126.
  • Pébay A., Toutant M., Prémont J., Calvo C. F., Venance L., Cordier J., Glowinski J. and Tencé M. (2001) Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur. J. Neurosci. 13, 20672076.
  • Pfeilschifter W., Czech-Zechmeister B., Sujak M., Mirceska A., Koch A., Rami A., Steinmetz H., Foerch C., Huwiler A. and Pfeilschifter J. (2011) Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem. Biophys. Res. Commun. 413, 212217.
  • Pitson S. M., Xia P., Leclercq T. M., Moretti P. A., Zebol J. R., Lynn H. E., Wattenberg B. W. and Vadas M. A. (2005) Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J. Exp. Med. 201, 4954.
  • Rajapakse N., Shimizu K., Payne M. and Busija D. (2001) Isolation and characterization of intact mitochondria from neonatal rat brain. Brain Res. Brain Res. Protoc. 8, 176183.
  • Sadakata T., Washida M., Iwayama Y. et al. (2007) Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117, 931943.
  • Saini H. S., Coelho R. P., Goparaju S. K., Jolly P. S., Maceyka M., Spiegel S. and Sato-Bigbee C. (2005) Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. J. Neurochem. 95, 12981310.
  • Saito M., Chakraborty G., Mao R. F., Wang R., Cooper T. B., Vadasz C. and Saito M. (2007a) Ethanol alters lipid profiles and phosphorylation status of AMP-activated protein kinase in the neonatal mouse brain. J. Neurochem. 103, 12081218.
  • Saito M., Mao R. F., Wang R., Vadasz C. and Saito M. (2007b) Effects of gangliosides on ethanol-induced neurodegeneration in the developing mouse brain. Alcohol. Clin. Exp. Res. 31, 665674.
  • Saito M., Chakraborty G., Hegde M., Ohsie J., Paik S. M., Vadasz C. and Saito M. (2010a) Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain. J. Neurochem. 115, 168177.
  • Saito M., Chakraborty G., Mao R. F., Paik S. M., Vadasz C. and Saito M. (2010b) Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochem. Res. 35, 651659.
  • Sankala H. M., Hait N. C., Paugh S. W., Shida D., Lépine S., Elmore L. W., Dent P., Milstien S. and Spiegel S. (2007) Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 67, 1046610474.
  • Shinpo K., Kikuchi S., Moriwaka F. and Tashiro K. (1999) Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res. 819, 170173.
  • Snider A. J., Orr Gandy K. A. and Obeid L. M. (2010) Spingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie 92, 707715.
  • Sorensen S. D., Nicole O., Peavy R. D., Montoya L. M., Lee C. J., Murphy T. J., Traynelis S. F. and Hepler J. R. (2003) Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Pharmacol. 64, 11991209.
  • Spiegel S. and Milstien S. (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397407.
  • Strub G. M., Paillard M., Liang J. et al. (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600612.
  • Takasugi N., Sasaki T., Suzuki K. et al. (2011) BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J. Neurosci. 31, 68506857.
  • Wacker B. K., Park T. S. and Gidday J. M. (2009) Hypoxic preconditioning-induced cerebral ischemic tolerance: role for microvasclar sphingosine kinase 2. Stroke 40, 33423348.
  • Wattenberg B. W. (2010) Role of sphingosine kinase localization in sphingolipid signaling. World J. Biol. Chem. 1, 362368.
  • Wu G., Lu Z. H. and Ledeen R. W. (1995) Induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. J. Neurosci. 15, 37393746.
  • Wu Y. P., Mizugishi K., Bektas M., Sandhoff R. and Proia R. L. (2008) Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. Hum. Mol. Genet. 17, 22572264.
  • Yamagata K., Tagami M., Torii Y., Takenaga F., Tsumagari S., Itoh Y., Yamori Y. and Nara Y. (2003) Sphingosine 1-phosphate induces the production of glial cell line-derived neurotrophic factor and cellular proliferation in astrocytes. Glia 41, 199206.
  • Young C., Roth K. A., Klocke B. J., West T., Holtzman D. M., Labruyere J., Qin Y. Q., Dikranian K. and Olney J. W. (2005) Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol. Dis. 20, 608614.
  • Yung L. M., Wei Y., Qin T., Wang Y., Smith C. D. and Waeber C. (2012) Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke 43, 199204.